These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 33427520)
1. Anti-tumor effect of local injectable hydrogel-loaded endostatin alone and in combination with radiotherapy for lung cancer. Wang N; Gao Q; Tang J; Jiang Y; Yang L; Shi X; Chen Y; Zhang Y; Fu S; Lin S Drug Deliv; 2021 Dec; 28(1):183-194. PubMed ID: 33427520 [TBL] [Abstract][Full Text] [Related]
2. Intratumoral injection of anlotinib hydrogel enhances antitumor effects and reduces toxicity in mouse model of lung cancer. Gao Q; Tang S; Chen H; Chen H; Li X; Jiang Y; Fu S; Lin S Drug Deliv; 2020 Dec; 27(1):1524-1534. PubMed ID: 33118422 [TBL] [Abstract][Full Text] [Related]
3. Synergistic effect and reduced toxicity by intratumoral injection of cytarabine-loaded hyaluronic acid hydrogel conjugates combined with radiotherapy on lung cancer. Tang J; Wang N; Wu J; Ren P; Li J; Yang L; Shi X; Chen Y; Fu S; Lin S Invest New Drugs; 2019 Dec; 37(6):1146-1157. PubMed ID: 30790151 [TBL] [Abstract][Full Text] [Related]
4. Intratumoral Injection of Anlotinib Hydrogel Combined With Radiotherapy Reduces Hypoxia in Lewis Lung Carcinoma Xenografts: Assessment by Micro Fluorine-18-fluoromisonidazole Positron Emission Tomography/Computed Tomography Hypoxia Imaging. Gao Q; Jiang Y; Li X; Chen H; Tang S; Chen H; Shi X; Chen Y; Fu S; Lin S Front Oncol; 2021; 11():628895. PubMed ID: 33777779 [TBL] [Abstract][Full Text] [Related]
5. Growth inhibitory effect of an injectable hyaluronic acid-tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells. Ueda K; Akiba J; Ogasawara S; Todoroki K; Nakayama M; Sumi A; Kusano H; Sanada S; Suekane S; Xu K; Bae KH; Kurisawa M; Igawa T; Yano H Acta Biomater; 2016 Jan; 29():103-111. PubMed ID: 26481041 [TBL] [Abstract][Full Text] [Related]
6. Preparation of endostatin-loaded chitosan nanoparticles and evaluation of the antitumor effect of such nanoparticles on the Lewis lung cancer model. Ding RL; Xie F; Hu Y; Fu SZ; Wu JB; Fan J; He WF; He Y; Yang LL; Lin S; Wen QL Drug Deliv; 2017 Nov; 24(1):300-308. PubMed ID: 28165807 [TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization. Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141 [TBL] [Abstract][Full Text] [Related]
8. Effect of endostatin on preventing postoperative progression of distant metastasis in a murine lung cancer model. Wang HL; Ning T; Li M; Lu ZJ; Yan X; Peng Q; Lei N; Zhang H; Luo F Tumori; 2011; 97(6):787-93. PubMed ID: 22322847 [TBL] [Abstract][Full Text] [Related]
9. Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-α2a for liver cancer therapy. Xu K; Lee F; Gao SJ; Chung JE; Yano H; Kurisawa M J Control Release; 2013 Mar; 166(3):203-10. PubMed ID: 23328125 [TBL] [Abstract][Full Text] [Related]
10. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy. Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486 [TBL] [Abstract][Full Text] [Related]
11. Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis. Jiang WG; Lu XA; Shang BY; Fu Y; Zhang SH; Zhou D; Li L; Li Y; Luo Y; Zhen YS BMC Cancer; 2013 Oct; 13():479. PubMed ID: 24128285 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of angiogenesis with a recombinant CTT peptide-endostatin mimic-kringle 5 protein. Wang H; Yang Z; Gu J Mol Cancer Ther; 2014 Nov; 13(11):2674-87. PubMed ID: 25127900 [TBL] [Abstract][Full Text] [Related]
13. Radiation-enhanced endostatin gene expression and effects of combination treatment. Luo X; Andres ML; Timiryasova TM; Fodor I; Slater JM; Gridley DS Technol Cancer Res Treat; 2005 Apr; 4(2):193-202. PubMed ID: 15773788 [TBL] [Abstract][Full Text] [Related]
14. Enzymatic conjugation of a bioactive peptide into an injectable hyaluronic acid-tyramine hydrogel system to promote the formation of functional vasculature. Wang LS; Lee F; Lim J; Du C; Wan AC; Lee SS; Kurisawa M Acta Biomater; 2014 Jun; 10(6):2539-50. PubMed ID: 24561710 [TBL] [Abstract][Full Text] [Related]
15. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206 [TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer. Wang R; Qin S; Chen Y; Li Y; Chen C; Wang Z; Zheng R; Wu Q Oncol Rep; 2012 Aug; 28(2):439-45. PubMed ID: 22641525 [TBL] [Abstract][Full Text] [Related]
17. Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin. Tan H; Yang S; Liu C; Cao J; Mu G; Wang F Biomed Pharmacother; 2012 Dec; 66(8):648-54. PubMed ID: 23122594 [TBL] [Abstract][Full Text] [Related]
18. Antiangiogenesis effects of endostatin in retinal neovascularization. Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016 [TBL] [Abstract][Full Text] [Related]
19. [Study on the Relationship Between Normalization of Tumor Microvessels and CA9 for Rh-Endostatin to Inhibit Lewis Lung Cancer]. He L; Sun YH; Liu K; Xu XX; Yang M; Wu X; Jiang L Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):342-346. PubMed ID: 28616903 [TBL] [Abstract][Full Text] [Related]
20. Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin. Bai RZ; Wu Y; Liu Q; Xie K; Wei YQ; Wang YS; Liu K; Luo Y; Su JM; Hu B; Liu JY; Li Q; Niu T; Zhao ZW; Yang L J Exp Clin Cancer Res; 2009 Mar; 28(1):31. PubMed ID: 19265510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]